SPANXB1 and cancer: As shown in Supplementary Figure 3, KRT19, FKBP10, GSK3B, and SPANXB1 have been investigated at the single-cell level in 9, 10, 16 and 3 types of cancer, respectively (Supplementary Figures 3A–D).